Global endocrine testing market to gain USD 10.50 billion by 2021, growing 8.5% CAGR between 2016 and 2021.
The report covers forecast and analysis for the endocrine testing market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the endocrine testing market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the endocrine testing market on a global level.
This report offers comprehensive coverage on global endocrine testing market along with, market trends, drivers and restraints of endocrine testing market. This report included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the endocrine testing market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness. This report is prepared using data sourced from in-house databases, secondary and primary research team of industry experts.
The study provides a decisive view on the endocrine testing market by segmenting the market based on test, technology, end-user and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The test market covered under this study includes Dehydroepiandrosterone sulfate (DHEAS), Progesterone, Luteinizing Hormone (LH), Estradiol (E2), Human Chorionic Gonadotropin (hCG), Follicle Stimulating (FSH), testosterone, thyroid prolactin, Thyroid Stimulating Hormone (TSH), cortisol, insulin, and other tests such as gastrin, thymosin, and secretin tests. Some of the key technologies in the market include monoclonal & polyclonal antibody technologies, tandem mass spectrometry, immunoassay, sensors, clinical chemistry technologies, and others. The end-users segmentation includes commercial laboratories, home-based tests, ambulatory care centers, hospitals and other. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global endocrine testing market include Bio Rad Laboratories, DiaSorin, Hoffmann-La Roche Ltd., LabCorp, and Quest Diagnostics, Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies and bioMerieux SA.
This report segments the global endocrine testing market as follows:
Global Endocrine Testing Market: Tests Segment Analysis
Global Endocrine Testing Market: Technology Segment Analysis
Global Endocrine Testing Market: End-user Segment Analysis
Global Endocrine Testing Market: Regional Segment Analysis
This report is based on in-depth qualitative and quantitative analyses of the global Endocrine Testing market. Zion Research has collected and analyzed key data belong to the global Endocrine Testing market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.
The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.
Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Endocrine Testing across the world has been calculated through primary and secondary research.
Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc.
For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in the validation of findings from secondary research and to understand key trends in the Endocrine Testing industry. Primary research makes up the major source of data collection and validation.
We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:
Participants who typically participate in such a process include, but are not limited to:
Key opinion leaders specializing in different areas corresponding to different industry verticals
Secondary research sources that are typically referred to include, but are not limited to:
News articles, press releases and webcasts specific to companies operating in the market
Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Endocrine Testing market.
Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:
The endocrine system is a very complex network that consists of several glands located throughout the body. Endocrine diagnostics test to measure the level of various hormones in a human body. It is also used to identify whether the endocrine glands are working properly. An optimally functioning endocrine system is essential to restoring and maintaining health.
Globally, the endocrine testing market has been accelerated on account of the rapid growth global geriatric population in both developed and developing countries. The changing lifestyles, increasing stress, and unhealthy food habits result in increased obesity and disturbed hormonal changes, which contributed substantially towards the growth of the endocrine diagnostics market. Moreover, increasing health awareness coupled with the government initiatives facilitated early diagnosis of endocrine disorders, which is expected to propel the demand for endocrine test kits. However, the high cost of technology is expected to be the major restraint for the growth of the endocrine testing market. Nonetheless, investment in research and technology is considered as a major opportunity for the growth of the global endocrine testing market.
The endocrine testing market can be segmented on the basis of test such as Dehydroepiandrosterone sulfate (DHEAS), Progesterone, Luteinizing Hormone (LH), Estradiol (E2), Human Chorionic Gonadotropin (hCG), Follicle Stimulating (FSH), testosterone, thyroid prolactin, Thyroid Stimulating Hormone (TSH), cortisol, insulin, and other tests such as gastrin, thymosin, and secretin tests. Thyroid stimulating hormone (TSH) was the leading segment owing to rising incidences of thyroid disorders and the growing awareness about the correlation between variations in the thyroid hormones levels and cardiovascular disorders. Insulin test is expected to witness the fastest growth in the years to come. This growth is mainly due to increase the rate of diabetes patients across the globe.
On the basis of technology, the market can be segmented into monoclonal & polyclonal antibody technologies, tandem mass spectrometry, immunoassay, sensors, clinical chemistry technologies, and others. Tandem mass spectrometry is expected to show significant growth in the years to come. Mass spectroscopy analysis is the most recent developed technology. The sensitivity of the tests by mass spectroscopy technology is very high.
Some of the key end-users include commercial laboratories, home-based tests, ambulatory care centers, hospitals and other healthcare settings. The commercial laboratories were the largest segment due to advanced infrastructure coupled with skilled personnel. The home-based test segment is growing fast with the introduction of new user-friendly and cost-effective diagnostic kits. This is expected to increase the penetration of home-based tests.
North America is projected to be the largest revenue contributing region. North America is expected to remain the dominant region over the next few years. Asia-Pacific is projected to be the fastest-growing region in the endocrine testing market during the forecast period as a result of demand from developing economies such as China and India. As a result of increasing aging population and increasing health awareness in Brazil, Latin America is also expected to experience significant growth in the years to come.
Some of the key players operating into this market include Bio Rad Laboratories, DiaSorin, Hoffmann-La Roche Ltd., LabCorp, Quest Diagnostics, Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies and bioMerieux SA.